Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
The Pharmacogenomics Journal|July 15, 2015
A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced coughJ D Mosley, C M Shaffer, S L Van Driest, et al.
Clinical Pharmacology and Therapeutics|February 10, 2016
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE networkW S Bush, D R Crosslin, A Owusu-Obeng, et al.
Clinical Pharmacology and Therapeutics|June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systemsL J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementationA R Shuldiner, M V Relling, J F Peterson, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
The Pharmacogenomics Journal|July 15, 2015
A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced coughJ D Mosley, C M Shaffer, S L Van Driest, et al.
Clinical Pharmacology and Therapeutics|February 10, 2016
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE networkW S Bush, D R Crosslin, A Owusu-Obeng, et al.
Clinical Pharmacology and Therapeutics|June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systemsL J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementationA R Shuldiner, M V Relling, J F Peterson, et al.
Pageof 24